TY - JOUR T1 - Explainable Machine Learning models for Rapid Risk Stratification in the Emergency Department: A multi-center study JF - medRxiv DO - 10.1101/2020.11.25.20238386 SP - 2020.11.25.20238386 AU - William P.T.M. van Doorn AU - Floris Helmich AU - Paul M.E.L. van Dam AU - Leo H.J. Jacobs AU - Patricia M. Stassen AU - Otto Bekers AU - Steven J.R. Meex Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/04/2020.11.25.20238386.abstract N2 - Background Risk stratification of patients presenting to the emergency department (ED) is important for appropriate triage. Diagnostic laboratory tests are an essential part of the work-up and risk stratification of these patients. Using machine learning, the prognostic power and clinical value of these tests can be amplified greatly. In this study, we applied machine learning to develop an accurate and explainable clinical decision support tool model that predicts the likelihood of 31-day mortality in ED patients (the RISKINDEX). This tool was developed and evaluated in four Dutch hospitals.Methods Machine learning models included patient characteristics and available laboratory data collected within the first two hours after ED presentation, and were trained using five years of data from consecutive ED patients from the Maastricht University Medical Centre+ (Maastricht), Meander Medical Center (Amersfoort), and Zuyderland (Sittard and Heerlen). A sixth year of data was used to evaluate the models using area-under-the-receiver-operating-characteristic curve (AUROC) and calibration curves. The SHapley Additive exPlanations (SHAP) algorithm was used to obtain explainable machine learning models.Results The present study included 266,327 patients with 7.1 million laboratory results available. Models show high diagnostic performance with AUROCs of 0.94,0.98,0.88, and 0.90 for Maastricht, Amersfoort, Sittard and Heerlen, respectively. The SHAP algorithm was utilized to visualize patient characteristics and laboratory data patterns that underlie individual RISKINDEX predictions.Conclusions Our clinical decision support tool has excellent diagnostic performance in predicting 31-day mortality in ED patients. Follow-up studies will assess whether implementation of these algorithm can improve clinically relevant endpoints.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a Noyons Stipendium from the Dutch Federation of Clinical Chemistry (NVKC). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the medical ethical committees of each of the individual centers (Maastricht: #2018-0838, Amersfoort: TWO19-46, Sittard: #2018-0838, Heerlen: #2018-0838). The study follows the STROBE guidelines and was conducted according to the principles of the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files. The raw data and analysis code for this study are available on reasonable request. ER -